Molecular Sales Consultant Jobs in Salt Lake City, UT at Myriad Genetics, Inc

Title: Molecular Sales Consultant

Company: Myriad Genetics, Inc

Location: Salt Lake City, UT

Salary: $80K — $100K *

Category: Pharmaceuticals & Biotech

Job Description

Myriad Neuroscience is looking for top sales talent and individuals who are passionate about improving patients’ lives. GeneSight is the industry leading mental health pharmacogenomic tool that is gaining rapid momentum via clinician adoption and recent positive coverage decisions from large insurance providers. As a Molecular Sales Consultant, you will actively expand the business while providing support to existing business within our focused market of psychiatric practices and additional practices treating mental health. This is not just another sales job, rather a unique opportunity to be on the leading edge of an industry defining product. At Myriad Neuroscience, you will have the chance to build a career with an organization that defines it’s culture by putting patients and people first. The Molecular Sales Consultant in South St. Louis will cover a territory that includes south metropolitan St. Louis and suburbs and extends to rural areas of southeastern Missouri. This position reports to the Regional Business Manager and perform the following job duties:

Identify, develop and manage commercial relationships with key opinion leaders in psychiatric medicine and other key healthcare professionals

Identify and capitalize on commercial opportunities for growth within a specific region or geography – predominately in the traditional out-patient practices, but also inclusive of institutions, local insurance payors, physician groups, long term care facilities, etc.

Manage full lifecycle of the product sales process, including new business development and lead generation via programs and other initiatives

Collaboration with the marketing team on the development of sales and marketing collateral

Attend local tradeshows, industry conferences and networking events

Staying current on industry and marketplace trends in the areas of psychiatry, behavioral health, and personalized medicine


Bachelor’s degree required

Must have a minimum of 3+ years of behavioral health / diagnostic sales / specialty pharmaceutical sales experience

Specific knowledge in psychiatric illnesses, psychopharmacology and personalized medicine is strongly preferred

Salesforce.com or similar CRM experience required

Demonstrated experience in developing and managing commercial relationships with physicians, physician practices, patient advocacy groups and key opinion leaders

Verifiable track record with building and growing a sales territory by managing the implementation of commercial programs and sales initiatives

Exceptional written, verbal and interpersonal communication skills

Excellent time management, scheduling, and organizational skills

Ability to manage multiple tasks in a fast-paced environment and work effectively under tight timelines and schedules

Ability to work independently and as a contributing team member

Ability to sense the importance or impact of issues/situations and take appropriate actions

Must be flexible, innovative, and self-motivated

Must have the flexibility to work extra hours to meet corporate and departmental goals.

Preferred product launch experience

See Less

Valid through: 9/15/2020


About Myriad Genetics, Inc

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individuals risk for developing disease later in life (predictive medicine), identify a patients likelihood of responding to a particular drug therapy (personalized medicine), assess a patients risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriads discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: “There is no more exciting story in medical science.” Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics. In August 2016 Myriad announced it would acquire Assurex Health for up to $410 million, expanding the companys genetic testing for psychotropic medicine selection. The global search for the genetic basis of breast and ovarian cancers began in earnest in 1988. In 1990, at an American Society of Human Genetics Meeting, a team of scientists led by Mary-Claire King, Ph.D., from University of California, Berkeley announced the localization through linkage analysis of a gene associated with increased risk for breast cancer (BRCA1) to the long arm of chromosome 17. In August 1994, Mark Skolnick and researchers at Myriad, along with colleagues at the University of Utah, the U.S National Institutes of Health (NIH), and McGill University sequenced BRCA1. In 2013, the actress Angelina Jolie had her ovaries removed because she tested positive for a mutation in the BRCA1 gene. This led to a surge in demand by women for genetic testing.